Drug recall · March 5, 2025
Avastin 1.25 mg/0.05 mL in 0.25 mL Syringe recall
Why: Lack of Assurance of Sterility: due to a quality control process deviation
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Avastin 1.25 mg/0.05 mL in 0.25 mL Syringe, For Intravitreal Injection Only, Office Use Only - Not for Resale - Single Use, This drug product was repackaged by Turbare Manufacturing, 925 Jeanette Drive, Conway, AR 72032, NDC: 83556-0101-01.
- Lots / codes
Lot #s: 12122024@2 (BUD: 3/12/2025); 12192024@2 (BUD: 4/18/2025).
- Quantity
- 1,147 syringes
- Company
- Turbare Manufacturing, Conway, AR
- Distribution
- Nationwide in the USA
- Initiated
- February 18, 2025 · Voluntary: Firm initiated
- Classified
- February 21, 2025
- Reported
- March 5, 2025
- Ended
- February 26, 2026
- How notified
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.